A. Feeney

Molecular Medicine · 2012

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom A. Feeney trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. L. Rice

Papers from A. Feeney's perspective

Ordered by how strongly the researchers A. Feeney trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. (Journal of Infectious Diseases)
  2. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. (Chest)
  3. Trends in antimicrobial drug development: implications for the future. (Clinical Infectious Diseases)
  4. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. (Clinical Infectious Diseases)
  5. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. (Clinical Infectious Diseases)
  6. Global Challenge of Multidrug-Resistant Acinetobacter baumannii (Antimicrobial Agents and Chemotherapy)
  7. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. (Clinical Infectious Diseases)
  8. Genomic insights that advance the species definition for prokaryotes. (Proceedings of the National Academy of Sciences of the United States of America)
  9. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. (Clinical Infectious Diseases)
  10. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. (Clinical Infectious Diseases)

Their papers